Evidence map›Paper›PMID 27824151›Full record

ArticleScientific reports2016

The Antimicrobial Susceptibility of Klebsiella pneumoniae from Community Settings in Taiwan, a Trend Analysis.

Wu-Pu Lin, Jann-Tay Wang, Shan-Chwen Chang, Feng-Yee Chang, Chang-Phone Fung, Yin-Ching Chuang, Yao-Shen Chen, Yih-Ru Shiau, Mei-Chen Tan, Hui-Ying Wang and 3 more

Abstract read
In one paragraph

Article in Scientific reports, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Multicenter study on clinical outcomes and poor prognostic factors in patients with Klebsiella pneumoniae bacteremia receiving cefoperazone/sulbactam treatment.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2024
    Article
  5. Article
  6. Resistome Analysis ofMicroorganisms · 2024
    Article
  7. Antimicrobial resistance trends in clinicalAfrican journal of laboratory medicine · 2024
    Article
  8. Article
  9. Article
  10. High Frequency ofInfection & chemotherapy · 2023
    Article
  11. Infection Sources andAntibiotics (Basel, Switzerland) · 2022
    Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Wu-Pu LinDepartment of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.
Jann-Tay WangDepartment of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.
Shan-Chwen ChangDepartment of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.
Feng-Yee ChangDivision of Infectious Diseases and Tropical Medicine, Tri-Service General Hospital, Taipei, Taiwan.
Chang-Phone FungDivision of Infectious Diseases, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan.
Yin-Ching ChuangDepartment of Internal Medicine, Chi-Mei Medical Center, Tainan, Taiwan.
Yao-Shen ChenDepartment of Medicine, Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan.
Yih-Ru ShiauNational Institute of Infectious Diseases and Vaccinology, National Health Research Institutes, Zhunan, Taiwan.
Mei-Chen TanNational Institute of Infectious Diseases and Vaccinology, National Health Research Institutes, Zhunan, Taiwan.
Hui-Ying WangNational Institute of Infectious Diseases and Vaccinology, National Health Research Institutes, Zhunan, Taiwan.
Jui-Fen LaiNational Institute of Infectious Diseases and Vaccinology, National Health Research Institutes, Zhunan, Taiwan.
I-Wen HuangNational Institute of Infectious Diseases and Vaccinology, National Health Research Institutes, Zhunan, Taiwan.
Tsai-Ling LauderdaleNational Institute of Infectious Diseases and Vaccinology, National Health Research Institutes, Zhunan, Taiwan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Drug-resistant Klebsiella pneumoniae, especially extended-spectrum β-lactamase (ESBL)- and/or AmpC β-lactamase-producing strains, is an emerging problem worldwide. However, few data focusing on drug susceptibility of K. pneumoniae from community is available. In this study, we analyzed 1016 K. pneumoniae isolates from outpatients or those visiting emergency rooms collected during 2002-2012 from Taiwan Surveillance of Antimicrobial Resistance program. Significantly decreased susceptibilities to 3

Indexed as

AdultAgedAged, 80 and overAnti-Bacterial AgentsCefotaximeCephalosporinsCiprofloxacinGenetic VariationHumansKlebsiella InfectionsKlebsiella pneumoniaeMicrobial Sensitivity TestsMiddle AgedMultilocus Sequence TypingPhylogenyPopulation SurveillanceAnti-Bacterial AgentsCefotaximeCephalosporinsCiprofloxacin

Identifiers

PMID27824151
PMCPMC5099973

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.